The pathogenesis of recurrent pericarditis is still poorly understood and may be related either to viral infections or autoimmune and autoinflammatory disorders. The immune system plays a major role in the pathogenesis of the disease, modulating individual responses to different noxa and explaining the variable reported recurrence rate (ranging from 20% to 50% of patients) following an attack of acute or recurrent pericarditis. Increasing interest is currently being devoted to autoinflammatory disorders, a group of conditions characterized by spontaneously relapsing and remitting bouts of systemic inflammation without apparent involvement of antigen-specific T cells or significant production of auto-antibodies. Ongoing basic and clinical research is needed to provide further evidence for the understanding of this common and troublesome disease, and to develop targeted and more efficacious therapies.
Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis / L. Cantarini, M. Imazio, A.L. Brucato, M. Lucherini Orso, M. Galeazzi. - In: AUTOIMMUNITY REVIEWS. - ISSN 1568-9972. - 9:6(2010), pp. 436-440.
Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis
A.L. Brucato;
2010
Abstract
The pathogenesis of recurrent pericarditis is still poorly understood and may be related either to viral infections or autoimmune and autoinflammatory disorders. The immune system plays a major role in the pathogenesis of the disease, modulating individual responses to different noxa and explaining the variable reported recurrence rate (ranging from 20% to 50% of patients) following an attack of acute or recurrent pericarditis. Increasing interest is currently being devoted to autoinflammatory disorders, a group of conditions characterized by spontaneously relapsing and remitting bouts of systemic inflammation without apparent involvement of antigen-specific T cells or significant production of auto-antibodies. Ongoing basic and clinical research is needed to provide further evidence for the understanding of this common and troublesome disease, and to develop targeted and more efficacious therapies.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1568997209001992-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
342.72 kB
Formato
Adobe PDF
|
342.72 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.